Shots:Eli spoke about the P-III IMAGINE study protocol evaluating Clazakizumab along with 6 articles by several experts published in the American Journal of TransplantationEli then talked about Clazakizumab's potential mechanism of action currently under investigationThe interview shows how CSL Behring works to develop and deliver innovative therapies for people living with conditions in…
